<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="1436">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on December 16, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05142462</url>
  </required_header>
  <id_info>
    <org_study_id>EC-310-01-01</org_study_id>
    <secondary_id>2021-A01650-41</secondary_id>
    <nct_id>NCT05142462</nct_id>
  </id_info>
  <brief_title>Post Market Clinical Follow-up of EUROSCUP Fixe Acetabular Cup</brief_title>
  <official_title>Post Market Clinical Follow-up of EUROSCUP Fixe Acetabular Cup</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>EUROS</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>EUROS</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      EUROSCUP Fixe is intended for use in primary and revision total hip replacement surgery.&#xD;
&#xD;
      Hip replacement is intended to provide increased patient mobility and reduce pain by&#xD;
      replacing the damages hip joint articulation in patients where there is evidence of&#xD;
      sufficient sound bone to seat and support the components.&#xD;
&#xD;
      As part of post market vigilance, EUROS will collect data on EUROSCUP Fixe performances and&#xD;
      safety&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Post market observational study. This study is retropective and prospective, non comparative.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 27, 2021</start_date>
  <completion_date type="Anticipated">April 2033</completion_date>
  <primary_completion_date type="Anticipated">April 2024</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Other</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Safety of EUROSCUP Fixe</measure>
    <time_frame>1 year</time_frame>
    <description>Collect the safety of the device trought complications occurence rate</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Clinical performances of EUROSCUP Fixe</measure>
    <time_frame>1 year</time_frame>
    <description>Collect the performances of the device trought clinical scores</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Radiological performances of EUROSCUP Fixe</measure>
    <time_frame>1 year</time_frame>
    <description>Collect the performances of the device trought radiological evaluation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Survival of EUROSCUP Fixe</measure>
    <time_frame>10 years</time_frame>
    <description>Assess the survival rate of the device</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Hip Arthropathy</condition>
  <condition>Hip Osteoarthritis</condition>
  <condition>Hip Necrosis</condition>
  <condition>Hip Fractures</condition>
  <condition>Hip Dysplasia</condition>
  <condition>Hip Arthritis</condition>
  <arm_group>
    <arm_group_label>EUROSCUP Fixe</arm_group_label>
    <description>120 patients who received EUROSCUP Fixe</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Hip arthroplasty</intervention_name>
    <description>Hip prosthesis surgical implantation</description>
    <arm_group_label>EUROSCUP Fixe</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patient who fulfill the criteria of eligilibilty according to the instructions for use of&#xD;
        EUROSCUP Fixe&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patient who received EUROSCUP Fixe.&#xD;
&#xD;
          -  Patient informed of its participation to the study&#xD;
&#xD;
          -  Patient aged between 18 and 80 years old (&lt;80).&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patient presenting a contraindication to EUROSCUP Fixe implantation.&#xD;
&#xD;
          -  Patient who refused to participate to the study&#xD;
&#xD;
          -  Vulnerable subjects&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
  </eligibility>
  <location>
    <facility>
      <name>Clinique Esquirol Saint Hilaire</name>
      <address>
        <city>Agen</city>
        <zip>47000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Damien LAQUES, Dr</last_name>
      <phone>05 53 47 47 47</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Clinique de L'Atlantique</name>
      <address>
        <city>Puilboreau</city>
        <zip>17138</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cedric Bouquet, Dr</last_name>
      <phone>05 36 28 85 00</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier SECLIN</name>
      <address>
        <city>Seclin</city>
        <zip>59113</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michael AMZALLAG, Dr</last_name>
      <phone>03 20 62 70 00</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Clinique St Roch</name>
      <address>
        <city>Toulon</city>
        <zip>83000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christophe MICHAUT, Dr</last_name>
      <phone>04 94 18 89 00</phone>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>November 24, 2021</study_first_submitted>
  <study_first_submitted_qc>November 24, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">December 2, 2021</study_first_posted>
  <last_update_submitted>November 24, 2021</last_update_submitted>
  <last_update_submitted_qc>November 24, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">December 2, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Joint Diseases</mesh_term>
    <mesh_term>Osteoarthritis, Hip</mesh_term>
    <mesh_term>Hip Dislocation</mesh_term>
    <mesh_term>Developmental Dysplasia of the Hip</mesh_term>
    <mesh_term>Hip Dislocation, Congenital</mesh_term>
    <mesh_term>Necrosis</mesh_term>
    <mesh_term>Hip Fractures</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

